Zydus Cadila gets USFDA’s nod for Emtricitabine, Tenofovir Disoproxil Fumarate tablets

04 Mar 2020 Evaluate

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg (US RLD: Truvada Tablets) and tentative approval for the strengths of 100 mg/ISO mg, 133 mg/200 mg, and 167 mg/250 mg, of the same drug.

This product is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in the body so the immune system can work better. This will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.

The group now has 281 approvals and has so far filed over 386 ANDAS since the commencement of the filing process in FY 2003-04.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×